2,4-thiazolidinedione has been researched along with Pulmonary Arterial Hypertension in 1 studies
thiazolidine-2,4-dione: structure in first source
1,3-thiazolidine-2,4-dione : A thiazolidenedione carrying oxo substituents at positions 2 and 4.
Pulmonary Arterial Hypertension: A progressive rare pulmonary disease characterized by high blood pressure in the PULMONARY ARTERY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hansmann, G | 1 |
| Calvier, L | 1 |
| Risbano, MG | 1 |
| Chan, SY | 1 |
1 review available for 2,4-thiazolidinedione and Pulmonary Arterial Hypertension
| Article | Year |
|---|---|
Activation of the Metabolic Master Regulator PPARĪ³: A Potential PIOneering Therapy for Pulmonary Arterial Hypertension.
Topics: Animals; Familial Primary Pulmonary Hypertension; Humans; Hypertension, Pulmonary; Muscle, Smooth, V | 2020 |